Multiple Sclerosis Journal - Experimental, Translational and Clinical : Impact Factor & More
eISSN: 2055-2173pISSN: 2055-2173
Open AccessShare this on:
Key Metrics
CiteScore 
3.3
SJR
Q4Neurology (clinical)
SNIP
0.8
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Multiple Sclerosis Journal - Experimental, Translational and Clinical
Multiple Sclerosis Journal - Experimental, Translational and Clinical Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | SAGE PUBLICATIONS INC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2000 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Multiple Sclerosis Journal - Experimental, Translational and Clinical ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Multiple Sclerosis Journal - Experimental, Translational and Clinical
Reinitiating ocrelizumab with a full 600\u2005mg dose after extended treatment interruption: No increased risk of infusion-related reactions
- 15 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Myelin damage in radiologically isolated syndrome is associated with decreased processing speed
- 15 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Discrepancy between subjective and objective cognitive function in multiple sclerosis and association with mood, fatigue, and pain
- 13 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Men's health research priorities in men with multiple sclerosis
- 9 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Neuromyelitis optica spectrum disorder in Germany: A claims data analysis of incidence, prevalence, treatment patterns, and diagnostic overlap with multiple sclerosis
- 7 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Long-term follow-up of patients with multiple sclerosis over age 60: Comparing clinical and radiological outcomes in disease-modifying therapy continuers and discontinuers
- 6 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Reinitiating ocrelizumab with a full 600\u2005mg dose after extended treatment interruption: No increased risk of infusion-related reactions
- 15 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Myelin damage in radiologically isolated syndrome is associated with decreased processing speed
- 15 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Discrepancy between subjective and objective cognitive function in multiple sclerosis and association with mood, fatigue, and pain
- 13 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Men's health research priorities in men with multiple sclerosis
- 9 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Neuromyelitis optica spectrum disorder in Germany: A claims data analysis of incidence, prevalence, treatment patterns, and diagnostic overlap with multiple sclerosis
- 7 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
Long-term follow-up of patients with multiple sclerosis over age 60: Comparing clinical and radiological outcomes in disease-modifying therapy continuers and discontinuers
- 6 May 2026
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
FAQs on Multiple Sclerosis Journal - Experimental, Translational and Clinical
How long has Multiple Sclerosis Journal - Experimental, Translational and Clinical been actively publishing? 
What is the publishing frequency of Multiple Sclerosis Journal - Experimental, Translational and Clinical?
How many articles did Multiple Sclerosis Journal - Experimental, Translational and Clinical publish last year?
What is the eISSN & pISSN for Multiple Sclerosis Journal - Experimental, Translational and Clinical?
What is Citescore for Multiple Sclerosis Journal - Experimental, Translational and Clinical?
What is SNIP score for Multiple Sclerosis Journal - Experimental, Translational and Clinical?
What is the SJR for Multiple Sclerosis Journal - Experimental, Translational and Clinical?
Who is the publisher of Multiple Sclerosis Journal - Experimental, Translational and Clinical?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations